8-K Announcements
6Material company update
May 12, 2026·SEC
Material company update
Feb 10, 2026·SEC
Material company update
Dec 18, 2025·SEC
Electromed, Inc.(ELMD)Earnings, Financials & Key Ratios
ELMD•AMEX
45.0× P/E·Price updated Jun 19, 2026
AboutElectromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.Show more
- Revenue$64M+17.0%
- EBITDA$11M+48.8%
- Net Income$8M+46.3%
- EPS (Diluted)0.86+48.3%
- Gross Margin78.08%+2.4%
- EBITDA Margin17.26%+27.2%
- Operating Margin15.43%+28.2%
- Net Margin11.78%+25.1%
- ROE17.18%+37.1%
ELMD Key Insights
Electromed, Inc. (ELMD) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong Piotroski F-Score: 7/9
- ✓FCF machine: 17.3% free cash flow margin
- ✓Momentum leader: RS Rating 91 (top 9%)
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 14.5%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ELMD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ELMD Price & Volume
Electromed, Inc. (ELMD) stock price & volume — 10-year historical chart
Loading chart...
ELMD Growth Metrics
Electromed, Inc. (ELMD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years12.67%
5 Years14.53%
3 Years15.39%
TTM16.79%
Profit CAGR
10 Years21.3%
5 Years12.62%
3 Years48.43%
TTM41.1%
EPS CAGR
10 Years20.8%
5 Years12.84%
3 Years49%
TTM48.1%
Return on Capital
10 Years14.96%
5 Years13.7%
3 Years16.53%
Last Year22.46%
ELMD Recent Earnings
Electromed, Inc. (ELMD) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 12, 2026Metric
Actual
Est
EPS
$0.35+34.6%
$0.26
Rev
$19M+5.5%
$18M
Q1 2026
Feb 10, 2026Metric
Actual
Est
EPS
$0.32+18.5%
$0.27
Rev
$19M+4.7%
$18M
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.25+13.6%
$0.22
Rev
$17M-7.7%
$18M
Q3 2025
Aug 26, 2025Metric
Actual
Est
EPS
$0.25+13.6%
$0.22
Rev
$17M+6.4%
$16M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 12, 2026 | $0.35vs $0.26+34.6% | $19Mvs $18M+5.5% |
| Q1 2026 | Feb 10, 2026 | $0.32vs $0.27+18.5% | $19Mvs $18M+4.7% |
| Q4 2025 | Nov 12, 2025 | $0.25vs $0.22+13.6% | $17Mvs $18M-7.7% |
| Q3 2025 | Aug 26, 2025 | $0.25vs $0.22+13.6% | $17Mvs $16M+6.4% |
Based on last 12 quarters of dataView full earnings history →
ELMD Peer Comparison
Electromed, Inc. (ELMD) competitors in Respiratory and sleep therapy devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 INGN | 173.55M | 6.41 | -7.54 | 3.86% | -7.08% | -12.9% | 0.09 | |
 LNTH | 6.76B | 103.86 | 30.46 | 0.5% | 18.05% | 24.33% | 0.00 | |
 LUNG | 54.06M | 1.28 | -0.96 | 8.01% | -59.67% | -82.79% | 1.04 | |
 SPXC | 12.19B | 242.97 | 48.02 | 14.17% | 10.8% | 12.37% | 0.22 | |
 ABT | 153.68B | 88.38 | 11.57 | 4.59% | 31.88% | 27.26% | 0.32 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 | |
 PHG | 25.5B | 26.78 | 25.02 | -1.04% | 5.49% | 8.96% | 0.74 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 |
Compare ELMD vs Peers
Electromed, Inc. (ELMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ELMD Income Statement
Electromed, Inc. (ELMD) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 25.86M | 28.31M | 31.3M | 32.47M | 35.76M | 41.66M | 48.07M | 54.72M | 64M | 71.75M |
Revenue Growth % | 12.48% | 9.46% | 10.57% | 3.74% | 10.12% | 16.51% | 15.38% | 13.83% | 16.97% | 16.79% |
Cost of Goods Sold | 5.29M | 6.53M | 7.45M | 7.27M | 8.45M | 10.22M | 11.55M | 12.99M | 14.03M | 15.47M |
COGS % of Revenue | 20.47% | 23.08% | 23.81% | 22.39% | 23.64% | 24.53% | 24.02% | 23.74% | 21.92% | - |
Gross Profit | 20.57M▲ 0% | 21.77M▲ 5.9% | 23.85M▲ 9.5% | 25.2M▲ 5.7% | 27.3M▲ 8.4% | 31.44M▲ 15.2% | 36.52M▲ 16.1% | 41.73M▲ 14.3% | 49.97M▲ 19.8% | 56.28M▲ 0% |
Gross Margin % | 79.53% | 76.92% | 76.19% | 77.61% | 76.36% | 75.47% | 75.98% | 76.26% | 78.08% | 78.44% |
Gross Profit Growth % | 15.06% | 5.85% | 9.53% | 5.67% | 8.35% | 15.15% | 16.15% | 14.26% | 19.76% | - |
Operating Expenses | 17M | 19.06M | 21.02M | 20.08M | 24.16M | 28.47M | 32.51M | 35.15M | 40.1M | 42.98M |
OpEx % of Revenue | 65.73% | 67.33% | 67.15% | 61.85% | 67.58% | 68.34% | 67.64% | 64.23% | 62.65% | - |
Selling, General & Admin | 16.4M | 18.81M | 20.44M | 19.95M | 22.44M | 27.11M | 31.59M | 34.49M | 39.1M | 41.69M |
SG&A % of Revenue | 63.42% | 66.45% | 65.29% | 61.42% | 62.77% | 65.09% | 65.73% | 63.03% | 61.1% | - |
Research & Development | 596.88K | 251.44K | 583.31K | 1.05M | 1.72M | 1.36M | 916K | 656K | 996K | 1.29M |
R&D % of Revenue | 2.31% | 0.89% | 1.86% | 3.23% | 4.82% | 3.26% | 1.91% | 1.2% | 1.56% | - |
Other Operating Expenses | 0 | 0 | 0 | -913K | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 3.57M▲ 0% | 2.71M▼ 24.0% | 2.83M▲ 4.3% | 5.12M▲ 80.9% | 3.14M▼ 38.6% | 2.97M▼ 5.4% | 4.01M▲ 34.9% | 6.58M▲ 64.2% | 9.87M▲ 50.0% | 13.31M▲ 0% |
Operating Margin % | 13.8% | 9.58% | 9.04% | 15.76% | 8.78% | 7.13% | 8.34% | 12.03% | 15.43% | 18.55% |
Operating Income Growth % | 14.8% | -24.01% | 4.33% | 80.87% | -38.65% | -5.35% | 34.86% | 64.2% | 50.01% | - |
EBITDA | 4.32M | 3.5M | 3.75M | 5.86M | 3.75M | 3.6M | 4.62M | 7.42M | 11.04M | 14.51M |
EBITDA Margin % | 16.72% | 12.37% | 12% | 18.04% | 10.49% | 8.64% | 9.61% | 13.56% | 17.26% | 20.22% |
EBITDA Growth % | 12.38% | -19.01% | 7.21% | 56.04% | -36% | -4% | 28.36% | 60.61% | 48.8% | 45.97% |
D&A (Non-Cash Add-back) | 755.13K | 790.03K | 925.23K | 741K | 610K | 628K | 613K | 841K | 1.17M | 1.2M |
EBIT | 3.57M | 2.71M | 2.83M | 5.12M | 3.14M | 2.97M | 4.01M | 6.58M | 9.87M | 13.31M |
Net Interest Income | -49.87K | 19.87K | 90.71K | 121K | 39K | 25K | 78K | 455K | 624K | 478K |
Interest Income | 17.04K | 19.87K | 90.71K | 120.75K | 39K | 25K | 78K | 455K | 624K | 478K |
Interest Expense | 66.91K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | -49.87K | 19.87K | 90.71K | 121K | 27K | 25K | 78K | 455K | 412K | 266K |
Pretax Income | 3.52M▲ 0% | 2.73M▼ 22.4% | 2.92M▲ 6.9% | 5.24M▲ 79.4% | 3.17M▼ 39.5% | 3M▼ 5.4% | 4.09M▲ 36.3% | 7.04M▲ 72.2% | 10.28M▲ 46.2% | 13.57M▲ 0% |
Pretax Margin % | 13.61% | 9.65% | 9.33% | 16.13% | 8.86% | 7.19% | 8.5% | 12.86% | 16.07% | 18.92% |
Income Tax | 1.29M | 901K | 940K | 1.08M | 805K | 692K | 920K | 1.89M | 2.75M | 3.47M |
Effective Tax Rate % | 36.65% | 32.98% | 32.19% | 20.58% | 25.42% | 23.09% | 22.52% | 26.81% | 26.71% | 25.56% |
Net Income | 2.23M▲ 0% | 1.83M▼ 17.9% | 1.98M▲ 8.1% | 4.16M▲ 110.1% | 2.36M▼ 43.2% | 2.31M▼ 2.4% | 3.17M▲ 37.4% | 5.15M▲ 62.7% | 7.54M▲ 46.3% | 10.1M▲ 0% |
Net Margin % | 8.62% | 6.47% | 6.33% | 12.81% | 6.61% | 5.53% | 6.59% | 9.41% | 11.78% | 14.08% |
Net Income Growth % | 0.77% | -17.87% | 8.15% | 110.12% | -43.23% | -2.41% | 37.35% | 62.67% | 46.35% | 41.1% |
Net Income (Continuing) | 2.23M | 1.83M | 1.98M | 4.16M | 2.36M | 2.31M | 3.17M | 5.15M | 7.54M | 10.1M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.26▲ 0% | 0.22▼ 15.4% | 0.23▲ 4.5% | 0.47▲ 104.3% | 0.27▼ 42.6% | 0.26▼ 3.7% | 0.36▲ 38.5% | 0.58▲ 61.1% | 0.86▲ 48.3% | 1.17▲ 0% |
EPS Growth % | -3.7% | -15.38% | 4.55% | 104.35% | -42.55% | -3.7% | 38.46% | 61.11% | 48.28% | 48.1% |
EPS (Basic) | 0.27 | 0.23 | 0.24 | 0.50 | 0.28 | 0.27 | 0.37 | 0.60 | 0.90 | - |
Diluted Shares Outstanding | 8.46M | 8.62M | 8.63M | 8.83M | 8.91M | 8.77M | 8.7M | 8.86M | 8.72M | 8.65M |
Basic Shares Outstanding | 8.17M | 8.21M | 8.31M | 8.4M | 8.57M | 8.47M | 8.46M | 8.56M | 8.33M | 8.21M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
ELMD Balance Sheet
Electromed, Inc. (ELMD) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 18.48M | 22.21M | 24.54M | 28.02M | 31.7M | 34.54M | 37.79M | 44.17M | 45.08M | 50.23M |
Cash & Short-Term Investments | 5.57M | 7.46M | 7.81M | 10.48M | 11.89M | 8.15M | 7.37M | 16.08M | 15.29M | 16.98M |
Cash Only | 5.57M | 7.46M | 7.81M | 10.48M | 11.89M | 8.15M | 7.37M | 16.08M | 15.29M | 16.98M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 9.95M | 12.59M | 13.76M | 13.84M | 17.43M | 21.34M | 24.62M | 24.05M | 25.7M | 28.25M |
Days Sales Outstanding | 140.43 | 162.31 | 160.41 | 155.62 | 177.88 | 186.96 | 186.93 | 160.45 | 146.55 | 136.7 |
Inventory | 2.56M | 2.36M | 2.62M | 3.08M | 2.11M | 3.18M | 4.22M | 3.71M | 3.3M | 3.29M |
Days Inventory Outstanding | 176.51 | 131.87 | 128.43 | 154.87 | 91.3 | 113.53 | 133.41 | 104.3 | 85.83 | 81.54 |
Other Current Assets | 0 | 0 | 0 | 262K | 0 | 0 | 1.58M | 1 | 408K | 1.7M |
Total Non-Current Assets | 4.58M | 4.43M | 4.82M | 5.22M | 5.41M | 6.83M | 8.02M | 8.06M | 8.72M | 9.25M |
Property, Plant & Equipment | 3.3M | 3.09M | 3.6M | 3.87M | 3.69M | 4.69M | 5.67M | 5.25M | 4.91M | 5.21M |
Fixed Asset Turnover | 7.83x | 9.16x | 8.68x | 8.39x | 9.68x | 8.89x | 8.47x | 10.42x | 13.03x | 13.89x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 721.28K | 649.1K | 581.41K | 598K | 663K | 599K | 605K | 657K | 1.32M | 354K |
Long-Term Investments | 0 | 0 | -44 | 0 | -88K | -120M | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 99.87K | 91.91K | 44 | 755K | 88K | 120M | 161K | 2.15M | 2.48M | 1.22M |
Total Assets | 23.06M▲ 0% | 26.64M▲ 15.5% | 29.35M▲ 10.2% | 33.24M▲ 13.3% | 37.11M▲ 11.6% | 41.36M▲ 11.5% | 45.81M▲ 10.7% | 52.23M▲ 14.0% | 53.8M▲ 3.0% | 59.47M▲ 0% |
Asset Turnover | 1.12x | 1.06x | 1.07x | 0.98x | 0.96x | 1.01x | 1.05x | 1.05x | 1.19x | 1.29x |
Asset Growth % | 12.01% | 15.51% | 10.2% | 13.25% | 11.62% | 11.47% | 10.74% | 14.03% | 3% | 31.04% |
Total Current Liabilities | 2.9M | 4.74M | 3.62M | 2.99M | 4.64M | 7.15M | 8.05M | 7.68M | 10.47M | 10.23M |
Accounts Payable | 663.38K | 810.64K | 586.58K | 556K | 685K | 1.26M | 1.37M | 1.01M | 2.67M | 2.6M |
Days Payables Outstanding | 45.75 | 45.28 | 28.73 | 27.91 | 29.59 | 45.05 | 43.37 | 28.38 | 69.39 | 63.24 |
Short-Term Debt | 50.7K | 1.1M | 0 | 0 | 33K | 0 | 80K | 0 | 0 | 0 |
Deferred Revenue (Current) | 1.54M | 397.39K | -30.32K | 0 | 0 | 1.54M | -80K | 0 | 0 | 0 |
Other Current Liabilities | 1.24M | 1.16M | 1.13M | 740K | 940K | -203K | 1.45M | 1.84M | 1.65M | 7.63M |
Current Ratio | 6.38x | 4.68x | 6.78x | 9.38x | 6.83x | 4.83x | 4.69x | 5.75x | 4.31x | 4.91x |
Quick Ratio | 5.50x | 4.19x | 6.05x | 8.35x | 6.38x | 4.39x | 4.17x | 5.27x | 3.99x | 4.59x |
Cash Conversion Cycle | 271.19 | 248.9 | 260.11 | 282.57 | 239.59 | 255.44 | 276.98 | 236.37 | 162.99 | 155.01 |
Total Non-Current Liabilities | 1.1M | 0 | 14.74K | 9K | 54K | 41K | 86K | 12K | 125K | 81K |
Long-Term Debt | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 14.74K | 9K | 54K | 41K | 81K | 12K | 125K | 125K |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | -1 | 0 | 0 | 5K | 0 | 0 | 81K |
Total Liabilities | 3.99M | 4.74M | 3.62M | 2.99M | 4.69M | 7.19M | 8.14M | 7.69M | 10.59M | 10.31M |
Total Debt | 1.15M | 1.1M | 45.06K | 81K | 87K | 41K | 161K | 87K | 198K | 0 |
Net Debt | -4.43M | -6.35M | -7.76M | -10.4M | -11.8M | -8.11M | -7.21M | -15.99M | -15.09M | -16.98M |
Debt / Equity | 0.06x | 0.05x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
Debt / EBITDA | 0.27x | 0.31x | 0.01x | 0.01x | 0.02x | 0.01x | 0.03x | 0.01x | 0.02x | 0.00x |
Net Debt / EBITDA | -1.02x | -1.81x | -2.07x | -1.77x | -3.15x | -2.25x | -1.56x | -2.15x | -1.37x | -1.17x |
Interest Coverage | 53.34x | - | - | - | - | - | - | - | - | - |
Total Equity | 19.07M▲ 0% | 21.9M▲ 14.8% | 25.73M▲ 17.5% | 30.25M▲ 17.5% | 32.42M▲ 7.2% | 34.17M▲ 5.4% | 37.67M▲ 10.2% | 44.55M▲ 18.3% | 43.21M▼ 3.0% | 49.17M▲ 0% |
Equity Growth % | 16.56% | 14.83% | 17.53% | 17.55% | 7.16% | 5.42% | 10.22% | 18.26% | -3% | 20.96% |
Book Value per Share | 2.25 | 2.54 | 2.98 | 3.43 | 3.64 | 3.90 | 4.33 | 5.03 | 4.96 | 5.69 |
Total Shareholders' Equity | 19.07M | 21.9M | 25.73M | 30.25M | 32.42M | 34.17M | 37.67M | 44.55M | 43.21M | 49.17M |
Common Stock | 82.3K | 82.89K | 84.08K | 86K | 85K | 85K | 86K | 87K | 83K | 83K |
Retained Earnings | 4.96M | 6.86M | 9.52M | 13.68M | 14.92M | 15.78M | 18.79M | 23.67M | 21.18M | 25.14M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -3.24M | -3.74M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ELMD Cash Flow Statement
Electromed, Inc. (ELMD) cash flow — operating, investing & free cash flow history
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 1.19M | 2.44M | 2.59M | 4.2M | 3.08M | -686K | 1.31M | 9.07M | 11.39M | 10.53M |
Operating CF Margin % | 4.61% | 8.63% | 8.27% | 12.92% | 8.61% | -1.65% | 2.74% | 16.57% | 17.8% | - |
Operating CF Growth % | -45.03% | 105.03% | 6.05% | 62.02% | -26.67% | -122.29% | 291.69% | 589.51% | 25.65% | -43.08% |
Net Income | 2.23M | 1.9M | 1.97M | 4.16M | 2.36M | 2.31M | 3.17M | 5.15M | 7.54M | 10.1M |
Depreciation & Amortization | 755.13K | 790.03K | 925.23K | 741K | 610K | 628K | 613K | 841K | 1.17M | 1.11M |
Stock-Based Compensation | 479.48K | 862.67K | 924.07K | 902K | 1.02M | 976K | 708K | 1.69M | 3.06M | 1.76M |
Deferred Taxes | -117K | -134K | -265K | -126K | -294K | -489K | -43K | -571K | -310K | -310K |
Other Non-Cash Items | 149.09K | 36.46K | 17.98K | 0 | 0 | 0 | 0 | 0 | 212K | 1.15M |
Working Capital Changes | -2.31M | -1.02M | -981.63K | -1.48M | -625K | -4.11M | -3.13M | 1.96M | -277K | -3.29M |
Change in Receivables | -2.34M | -1.61M | -948.73K | -350K | -3.58M | -3.91M | -3.28M | 565K | -1.64M | -3.56M |
Change in Inventory | -28.33K | 234.59K | -106.17K | -449K | 971K | -1.07M | -1.03M | 459K | 175K | -512K |
Change in Payables | -337.47K | 555.99K | -2.56K | -472K | 214K | 2.17M | 420K | -1.21M | 1.65M | 1.06M |
Cash from Investing | -687.15K | -571.78K | -1.39M | -977K | -448K | -1.52M | -1.72M | -395K | -306K | -1.23M |
Capital Expenditures | -687.15K | -571.78K | -1.39M | -844K | -287K | -1.52M | -1.72M | -395K | -306K | -311K |
CapEx % of Revenue | 2.66% | 2.02% | 4.44% | 2.6% | 0.8% | 3.66% | 3.57% | 0.72% | 0.48% | 0.43% |
Acquisitions | 0 | 0 | 1.75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -68.39K | -45.55K | -56.04K | -133K | -161K | 0 | 0 | 0 | 0 | -923K |
Cash from Financing | -53.62K | 11.71K | -851.15K | -548K | -1.22M | -1.52M | -380K | 36K | -11.88M | -7.55M |
Debt Issued (Net) | -48.75K | -50.7K | -1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 0 | 0 | 0 | 0 | -1.12M | -1.45M | -153K | -275K | -10M | -7.47M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | -1.12M | -1.45M | -153K | -275K | -10M | -7.59M |
Other Financing | -4.87K | 62.41K | 251.85K | -548K | -95K | -77K | -227K | 311K | -1.88M | -73K |
Net Change in Cash | 450.35K▲ 0% | 1.88M▲ 317.9% | 352.08K▼ 81.3% | 2.67M▲ 658.6% | 1.41M▼ 47.2% | -3.74M▼ 365.0% | -781K▲ 79.1% | 8.71M▲ 1215.0% | -793K▼ 109.1% | 1.75M▲ 0% |
Free Cash Flow | 503.97K▲ 0% | 1.87M▲ 271.1% | 1.2M▼ 35.8% | 3.22M▲ 167.9% | 2.63M▼ 18.3% | -2.21M▼ 184.1% | -401K▲ 81.9% | 8.67M▲ 2262.6% | 11.09M▲ 27.8% | 10.23M▲ 0% |
FCF Margin % | 1.95% | 6.61% | 3.84% | 9.91% | 7.35% | -5.31% | -0.83% | 15.85% | 17.32% | 14.25% |
FCF Growth % | -68.29% | 271.14% | -35.76% | 167.92% | -18.33% | -184.1% | 81.86% | 2262.59% | 27.85% | -14.38% |
FCF per Share | 0.06 | 0.22 | 0.14 | 0.36 | 0.30 | -0.25 | -0.05 | 0.98 | 1.27 | 1.18 |
FCF Conversion (FCF/Net Income) | 0.53x | 1.33x | 1.31x | 1.01x | 1.30x | -0.30x | 0.42x | 1.76x | 1.51x | 1.01x |
Interest Paid | 59.23K | 46K | 22.99K | 3.13K | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 1.09M | 1.02M | 1.31M | 1.75M | 534K | 1.42M | 676K | 2.51M | 3.74M | 1.6M |
ELMD Key Ratios
Electromed, Inc. (ELMD) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 12.59% | 8.94% | 8.32% | 14.87% | 7.54% | 6.92% | 8.81% | 12.53% | 17.18% | 22.14% |
Return on Invested Capital (ROIC) | 19.77% | 13.48% | 12.67% | 20.3% | 11.64% | 9.55% | 10.64% | 16.73% | 26.13% | 32.57% |
Gross Margin | 79.53% | 76.92% | 76.19% | 77.61% | 76.36% | 75.47% | 75.98% | 76.26% | 78.08% | 78.44% |
Net Margin | 8.62% | 6.47% | 6.33% | 12.81% | 6.61% | 5.53% | 6.59% | 9.41% | 11.78% | 14.08% |
Debt / Equity | 0.06x | 0.05x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
Interest Coverage | 53.34x | - | - | - | - | - | - | - | - | - |
FCF Conversion | 0.53x | 1.33x | 1.31x | 1.01x | 1.30x | -0.30x | 0.42x | 1.76x | 1.51x | 1.01x |
Revenue Growth | 12.48% | 9.46% | 10.57% | 3.74% | 10.12% | 16.51% | 15.38% | 13.83% | 16.97% | 16.79% |
Related:ELMD Dividend History·ELMD Revenue History·ELMD Price History·ELMD P/E History·ELMD Financial Ratios·ELMD Institutional Holders
ELMD SEC Filings & Documents
Electromed, Inc. (ELMD) SEC filings — annual & quarterly reports (10-K, 10-Q)
ELMD Frequently Asked Questions
Electromed, Inc. (ELMD) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Electromed, Inc. (ELMD) reported $71.8M in revenue for fiscal year 2025. This represents a 720% increase from $8.8M in 2008.
Electromed, Inc. (ELMD) grew revenue by 17.0% over the past year. This is strong growth.
Yes, Electromed, Inc. (ELMD) is profitable, generating $10.1M in net income for fiscal year 2025 (11.8% net margin).
Dividend & Returns
Electromed, Inc. (ELMD) has a return on equity (ROE) of 17.2%. This is reasonable for most industries.
Electromed, Inc. (ELMD) generated $10.2M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.